Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
published in: Lancet Oncology Commission
date of publication: 2012-08-13
main subject: phase II clinical trial, ipilimumab
Cites articles 27
- 2011-11-14
Date
Title
Article - wd:Q33402830